Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Garzotto

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Clinical Imaging|May 5, 2018
Endorectal MR imaging of prostate cancer: Evaluation of tumor capsular contact length as a sign of extracapsular extensionGustavo Mendez, Bryan R Foster, Xin Li, et al.
The Journal of Urology|March 20, 2018
Unconventional Bladder Preservation: Factors Predicting Failure to Receive Definitive Surgery following Chemotherapy for Nonmetastatic Muscle Invasive Bladder Cancer in the National Cancer DatabaseAkash A Kapadia, Ann Martinez Acevedo, Jen-Jane Liu, et al.
American Journal of Clinical Oncology|October 30, 2024
Safety and Efficacy of Neoadjuvant Docetaxel and Radiotherapy in Localized High-Risk Prostate Cancer: Results From a Prospective Pilot StudyKim C Ohaegbulam, Carl M Post, Paige E Farris, et al.
BJU International|August 3, 2016
Cyclooxygenase-2 (COX-2) inhibition for prostate cancer chemoprevention: double-blind randomised study of pre-prostatectomy celecoxib or placeboJason F Flamiatos, Tomasz M Beer, Julie N Graff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2005
Improved detection of prostate cancer using classification and regression tree analysisMark Garzotto, Tomasz M Beer, R Guy Hudson, et al.
Biochemical and Biophysical Research Communications|May 24, 2005
Resistance of prostate cancer cell lines to COX-2 inhibitor treatmentMatthew Wagner, James Loos, Nicole Weksler, et al.
Cancer|September 26, 2003
Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels < or = 10 ng/mLMark Garzotto, R Guy Hudson, Laura Peters, et al.
BJU International|August 18, 2005
Clinical outcomes of androgen deprivation as the sole therapy for localized and locally advanced prostate cancerDaniel M Janoff, Chad Peterson, Solange Mongoue-Tchokote, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Phase I study of weekly mitoxantrone and docetaxel before prostatectomy in patients with high-risk localized prostate cancerTomasz M Beer, Mark Garzotto, Bruce A Lowe, et al.
Nutrition and Cancer|September 21, 2016
Effects of ω-3 Fatty Acids and Catechins on Fatty Acid Synthase in the Prostate: A Randomized Controlled TrialZhenzhen Zhang, Mark Garzotto, Tomasz M Beer, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Clinical Imaging|May 5, 2018
Endorectal MR imaging of prostate cancer: Evaluation of tumor capsular contact length as a sign of extracapsular extensionGustavo Mendez, Bryan R Foster, Xin Li, et al.
The Journal of Urology|March 20, 2018
Unconventional Bladder Preservation: Factors Predicting Failure to Receive Definitive Surgery following Chemotherapy for Nonmetastatic Muscle Invasive Bladder Cancer in the National Cancer DatabaseAkash A Kapadia, Ann Martinez Acevedo, Jen-Jane Liu, et al.
American Journal of Clinical Oncology|October 30, 2024
Safety and Efficacy of Neoadjuvant Docetaxel and Radiotherapy in Localized High-Risk Prostate Cancer: Results From a Prospective Pilot StudyKim C Ohaegbulam, Carl M Post, Paige E Farris, et al.
BJU International|August 3, 2016
Cyclooxygenase-2 (COX-2) inhibition for prostate cancer chemoprevention: double-blind randomised study of pre-prostatectomy celecoxib or placeboJason F Flamiatos, Tomasz M Beer, Julie N Graff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2005
Improved detection of prostate cancer using classification and regression tree analysisMark Garzotto, Tomasz M Beer, R Guy Hudson, et al.
Biochemical and Biophysical Research Communications|May 24, 2005
Resistance of prostate cancer cell lines to COX-2 inhibitor treatmentMatthew Wagner, James Loos, Nicole Weksler, et al.
Cancer|September 26, 2003
Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels < or = 10 ng/mLMark Garzotto, R Guy Hudson, Laura Peters, et al.
BJU International|August 18, 2005
Clinical outcomes of androgen deprivation as the sole therapy for localized and locally advanced prostate cancerDaniel M Janoff, Chad Peterson, Solange Mongoue-Tchokote, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Phase I study of weekly mitoxantrone and docetaxel before prostatectomy in patients with high-risk localized prostate cancerTomasz M Beer, Mark Garzotto, Bruce A Lowe, et al.
Nutrition and Cancer|September 21, 2016
Effects of ω-3 Fatty Acids and Catechins on Fatty Acid Synthase in the Prostate: A Randomized Controlled TrialZhenzhen Zhang, Mark Garzotto, Tomasz M Beer, et al.
Pageof 8